If you suspect you've fallen for a digital payment app scam, contact the app and your financial institution immediately. There's no guarantee you can reclaim your stolen funds, but your bank may be ...

That’s why, as a 2016 Vox investigation found, there are many reports of vitamins and supplements containing ingredients that ...

15 analysts have expressed a variety of opinions on Hims & Hers Health HIMS over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below summarizes their ...

The knockoff surge was led by Hims & Hers Health, the telehealth firm that began selling the drugs last spring.

Investing.com -- Hims&Hers Health shares are down over 8% premarket Thursday after a federal judge ruled in favor of the FDA in the tirzepatide compounding case. Bank of America wrote in a note ...

Investing.com -- Hims & Hers Health shares are down over 8% premarket Thursday after a federal judge ruled in favor of the FDA in the tirzepatide compounding case. Bank of America wrote in a ...

The stock is down 10.5% as 2 p.m. ET on Friday, while the stock is still up 224% in the last year. Here's why Hims & Hers stock fell this week. Where to invest $1,000 right now? Our analyst team ...

Hims & Hers reported its Q4 earnings this week. The company is growing quickly but faces a potential legal threat to its weight loss drug program. It is guiding for margin expansion and fast ...

Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS. And retail traders should know. We noticed this today when the trades showed up on publicly available ...

Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) – Analysts at Seaport Res Ptn upped their Q1 2025 EPS estimates for Hims & Hers Health in a research note issued on Monday, February 24th.